PepGen
The Associate Director, Biostatistics at PepGen will serve as a statistical subject‑matter expert, supporting protocol development, study design, analysis, regulatory submissions, and publications for clinical programs, particularly in neuromuscular and rare diseases. The role involves collaboration with cross‑functional teams, oversight of CRO statistical activities, and contribution to biostatistics SOPs and standards.
Headquarters
Boston, Massachusetts, United States
Company Size
51-200 employees
Founded
2018
PepGen is a clinical-stage biotechnology company developing peptide-enabled oligonucleotide therapeutics to treat serious genetic neuromuscular and neurological diseases. Their proprietary Enhanced Delivery Oligonucleotide (EDO) platform is designed to improve cellular uptake and tissue targeting of genetic therapies, with programs targeting conditions such as Duchenne muscular dystrophy and myotonic dystrophy. PepGen advances its pipeline through preclinical and clinical development, combining peptide chemistry and nucleic-acid expertise to address the root causes of debilitating genetic diseases.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for PepGen.
Right around the average for this role